Edwards Lifesciences Corporation Share Price
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
21:00:02 15/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 88.10 USD | +1.91% |
|
+4.58% | +3.34% |
| 11:37pm | FDA flags Edwards heart-valve delivery system issue after death, injury | RE |
| 10-15 | Baird Adjusts Price Target on Edwards Lifesciences to $90 From $94 | MT |
| Market Cap | 50.78B 45.33B 42.13B 38.32B 72.09B 4,810B 73.39B 506B 198B 2,509B 191B 187B 8,030B | P/E 2026 * |
35.4x | P/E 2027 * | 26.5x |
|---|---|---|---|---|---|
| Enterprise Value | 47.15B 42.09B 39.12B 35.58B 66.94B 4,466B 68.15B 470B 184B 2,330B 177B 173B 7,456B | EV / Sales 2026 * |
6.97x | EV / Sales 2027 * | 6.13x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Tradegate
| EWL | Real-time | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Xetra
| EWL | Delayed | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +1.91% | ||
| 1 week | +4.58% | ||
| Current month | +2.06% | ||
| 1 month | +2.75% | ||
| 3 months | +0.95% | ||
| 6 months | +12.66% | ||
| Current year | +3.34% |
| 1 week | 84.55 |  | 88.41 |
| 1 month | 82.42 | | 89.66 |
| Current year | 74.66 | | 96.29 |
| 1 year | 72.67 | | 96.29 |
| 3 years | 58.93 | | 96.29 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 10/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 28/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 31/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 06/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 09/02/2015 |
| Director/Board Member | 58 | 10/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/10/26 | Exercice | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 14/09/26 | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 13/09/26 | Tax | Controller/Auditor | -253 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.91% | +4.58% | +20.80% | +24.47% | 50.78B | |
| +3.46% | +6.83% | +31.94% | +44.25% | 258B | |
| +3.03% | +6.46% | +12.32% | +10.54% | 163B | |
| +1.81% | +3.00% | -1.78% | +56.64% | 151B | |
| +2.65% | +5.00% | -54.83% | -10.86% | 63.97B | |
| +1.95% | +6.77% | -13.31% | -14.04% | 50.94B | |
| +0.89% | +4.39% | +25.71% | +58.85% | 49.49B | |
| +5.27% | +9.90% | +8.93% | +44.85% | 50.68B | |
| +1.73% | +3.50% | +33.62% | +75.82% | 43.64B | |
| -1.41% | +1.27% | +188.10% | +107.52% | 40.46B | |
| Average | +1.79% | +4.34% | +25.15% | +39.80% | 92.14B | |
| Weighted average by Cap. | +2.18% | +3.93% | +19.14% | +37.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76B 6.04B 5.61B 5.1B 9.6B 640B 9.77B 67.39B 26.37B 334B 25.38B 24.84B 1,069B | 7.43B 6.64B 6.17B 5.61B 10.55B 704B 10.74B 74.08B 28.98B 367B 27.9B 27.31B 1,176B |
| Net income | 1.44B 1.28B 1.19B 1.08B 2.04B 136B 2.07B 14.3B 5.6B 70.92B 5.39B 5.27B 227B | 1.9B 1.69B 1.57B 1.43B 2.69B 180B 2.74B 18.91B 7.4B 93.78B 7.12B 6.97B 300B |
| Net Debt | -3.63B -3.24B -3.01B -2.74B -5.15B -344B -5.25B -36.18B -14.16B -179B -13.63B -13.34B -574B | -5.19B -4.64B -4.31B -3.92B -7.37B -492B -7.51B -51.77B -20.25B -257B -19.49B -19.08B -821B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/10/26 | US$88.10 | +1.91% | 4,681,095 |
| 14/10/26 | US$86.45 | +1.38% | 4,036,660 |
| 13/10/26 | US$85.27 | -1.30% | 3,643,041 |
| 12/10/26 | US$86.39 | +1.38% | 3,324,390 |
| 09/10/26 | US$85.21 | +1.15% | 3,890,502 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
